PRESS RELEASE
Theramed Corporation and
BurnsAdler Pharmaceuticals, Inc. Sign Long Term Cooperation
Agreement.
Charlotte, North
Carolina – (February 10, 2003)
–
BurnsAdler Pharmaceuticals,
Inc. (“BurnsAdler”) announced today that it has entered into a
ten year promotional agreement with Theramed Corporation to
market select pharmaceutical products in Canada.
Banks Bourne, President of
BurnsAdler remarked, “Our team has worked with the owners and
executives of Theramed for several years and previously
licensed several products to the organization. We are
confident in Theramed’s promotional and regulatory
capabilities in the Canadian market.”
The Theramed Corporation is a
specialty pharmaceutical company focused on the in-licensing,
marketing and distribution of prescription pharmaceutical
products in
Canada.
The partnership agreement with BurnsAdler Pharmaceuticals is
expected to yield a steady pipeline of additional products for
Theramed to promote in Canada.
BurnsAdler is
an internationally focused
specialty pharmaceutical company that provides cost effective
product distribution and promotion for select emerging
pharmaceutical companies. BurnsAdler creates long term,
exclusive agreements which grant it the right to license,
supply and market products wherever their partners are
interested in generating additional revenue and profit. The
Company focuses on promoting products in
Europe, South America, Latin
America, Far East, Canada and the Caribbean.
For additional
information about this news release contact Molly Whitehurst
at +1.704.770.0994 Ext. 224. Find additional information
about BurnsAdler at
www.burnsadler.com.
Newsroom
Print this page.
